DCs bridge innate and adaptive immunity
11 and are considered the chief inducers of adaptive immune responses.
12 13 To this end, DCs that have captured infectious pathogens migrate to draining lymph nodes to activate T cells.
3 12 Some DCs remain in tissues, to modify the response of infiltrating T cells, which has also been observed in the eye.
10 The presence of DCs in the ocular environment appears paradoxical, especially because elaborate systems exist to maintain immunoprivilege.
14 Nevertheless, DCs have been demonstrated also in the eye by histology and immunohistochemistry in the cornea, iris, ciliary body, and choroid of different species.
15 16 17 18 19 20 21 Their exact role in the healthy and diseased eye remains largely unresolved, partially due to the lack of adequate experimental systems to study these rare cells. Forrester et al.
10 identified two types of DCs in the rat choroid: major histocompatibility complex (MHC) II
int nontranslocating cells and MHC class II
hi rapidly translocating cells, the latter of which probably represent matured DCs.
10 Under physiological conditions, tissue-traversing DCs have been proposed to prevent T-cell activation and thereby to maintain immune privilege and homeostasis in the eye.
10 DCs have been detected in the peripheral margins and juxtapapillary areas of the retinas of healthy mice, but not in inflammatory conditions.
20 22 In contrast, microglial cells (μGCs) are abundant in this site and form a dense network. These cells have been shown to be involved in the inflammatory response for example in ischemia- and kainate-induced retinal damage.
7 23 Their exact role as immune cells is still under intense investigation.
24